MaengMJensenLOFalkE.
Negative vascular remodelling after implantation of
bioabsorbable magnesium alloy stents in porcine coronary arteries: a
randomised comparison with bare-metal and sirolimus-eluting
stents. Heart.2009;95:241–246.
3.
HeubleinBRohdeRKaeseV.
Biocorrosion of magnesium alloys: a new principle in
cardiovascular implant technology?Heart.2003;89:651–656.
4.
WaksmanRPakalaRKuchulakantiPK.
Safety and efficacy of bioabsorbable magnesium alloy stents
in porcine coronary arteries. Catheter Cardiovasc
Interv.2006;68:607–617.
5.
ErbelRDi MarioCBartunekJ.
Temporary scaffolding of coronary arteries with bioabsorbable
magnesium stents: a prospective, non-randomised multicentre
trial. Lancet.2007;369:1869–1875.
6.
LiHZhongHXuK.
Enhanced efficacy of sirolimus-eluting bioabsorbable
magnesium alloy stents in prevention of restenosis.
J Endovasc Ther.2011;18:407–415.
7.
AndersenHRMaengMThorwestM.
Remodeling rather than neointimal formation explains luminal
narrowing after deep vessel wall injury. Insights from a porcine coronary
(re)stenosis model. Circulation.1996;93:1716–1724.
8.
MaengMOlesenPGEmmertsenNC.
Time course of vascular remodeling, formation of neointima
and formation of neoadventitia after angioplasty in a porcine
model. Coron Artery Dis.2001;12:285–293.
9.
KimuraTKaburagiSTamuraT.
Remodeling of human coronary arteries undergoing coronary
angioplasty or atherectomy. Circulation.1997;96:475–483.